Bayer OKs $415M Sale Of Device Unit To Boston Scientific
Bayer AG has agreed to the $415 million cash sale of its interventional device division to Boston Scientific Corp., Boston Scientific announced Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article